全文获取类型
收费全文 | 8513篇 |
免费 | 487篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 71篇 |
儿科学 | 203篇 |
妇产科学 | 81篇 |
基础医学 | 1127篇 |
口腔科学 | 155篇 |
临床医学 | 524篇 |
内科学 | 2180篇 |
皮肤病学 | 278篇 |
神经病学 | 617篇 |
特种医学 | 170篇 |
外科学 | 1174篇 |
综合类 | 38篇 |
一般理论 | 2篇 |
预防医学 | 354篇 |
眼科学 | 347篇 |
药学 | 750篇 |
中国医学 | 23篇 |
肿瘤学 | 941篇 |
出版年
2023年 | 50篇 |
2022年 | 131篇 |
2021年 | 218篇 |
2020年 | 140篇 |
2019年 | 147篇 |
2018年 | 229篇 |
2017年 | 174篇 |
2016年 | 225篇 |
2015年 | 187篇 |
2014年 | 256篇 |
2013年 | 346篇 |
2012年 | 509篇 |
2011年 | 519篇 |
2010年 | 290篇 |
2009年 | 270篇 |
2008年 | 479篇 |
2007年 | 513篇 |
2006年 | 501篇 |
2005年 | 475篇 |
2004年 | 499篇 |
2003年 | 409篇 |
2002年 | 418篇 |
2001年 | 195篇 |
2000年 | 203篇 |
1999年 | 185篇 |
1998年 | 112篇 |
1997年 | 81篇 |
1996年 | 56篇 |
1995年 | 62篇 |
1994年 | 55篇 |
1993年 | 58篇 |
1992年 | 109篇 |
1991年 | 71篇 |
1990年 | 77篇 |
1989年 | 97篇 |
1988年 | 93篇 |
1987年 | 75篇 |
1986年 | 64篇 |
1985年 | 73篇 |
1984年 | 45篇 |
1983年 | 41篇 |
1982年 | 24篇 |
1980年 | 21篇 |
1979年 | 25篇 |
1975年 | 17篇 |
1974年 | 16篇 |
1973年 | 14篇 |
1972年 | 21篇 |
1969年 | 26篇 |
1968年 | 24篇 |
排序方式: 共有9035条查询结果,搜索用时 15 毫秒
121.
Yamauchi K Yamaguchi N Furukawa T Takatsu K Nakanishi T Ishida K Komatsu T Tokushige K Nagahara H Hashimoto E Shiratori K 《Hepatology (Baltimore, Md.)》2005,42(1):149-155
We have previously reported an immunoglobulin (Ig) M autoantibody to hepatocyte-related 190-kd molecules in patients with type 1 autoimmune hepatitis (AIH). This molecule was first isolated by hepatocyte-specific human monoclonal antibody (MoAb). To elucidate the role of this IgM autoantibody in hepatocyte injury, we examined the reactivity of this MoAb to murine hepatocytes and then questioned whether acute hepatic injury could be induced in mice via injection of this MoAb. The reactivity of MoAb was examined via both FACS analysis using murine hepatocytes and immunostaining of liver tissues. We then identified the murine hepatocyte membrane molecule recognized by this MoAb. The role of this MoAb in the immunopathogenesis of AIH was assessed by testing whether its injection into mice could increase serum aminotransferase levels as well as cause changes in liver histology. The present results demonstrate that this MoAb cross-reacted with murine hepatocytes and recognized a 190-kd molecule on the murine hepatocyte membrane just as in human hepatocytes. One hour after the injection of MoAb, the deposition of both IgM and complement component 3 was found in liver tissues. At 8 hours after the injection, serum aminotransferase levels were significantly increased in MoAb-injected mice compared with controls. Histological study revealed massive hepatocyte necrosis in MoAb-injected mice. In conclusion, human MoAb recognized a 190-kd molecule of both human and murine hepatocytes, and the injection of this MoAb to mice resulted in acute liver injury, indicating that this type of autoantibody may play an important role in the immunopathogenesis of AIH. 相似文献
122.
To elucidate the role of early insulin response in post-prandial hyperlipidemia, we examined triglyceride (TG) and remnant-like particle triglyceride (RLP-TG) levels, using a meal tolerance test (MTT) with or without the administration of nateglinide (NAT). The MTTs were performed 2 d apart in 36 drug-naive patients with type 2 diabetes who had been hospitalized for glycemic control while receiving diet therapy. Before the second MTT, patients were treated with 90 mg NAT. Treatment with NAT was associated with a significant increase in insulin levels in the treated patients 1 h after the test meal, compared to levels in non-treatment. NAT treatment was also associated with a significant decrease in the level of free fatty acids 1 and 2 h after the meal, and with a significant decrease in plasma glucose levels 1, 2, and 4 h after the meal, compared to those in non-treatment. During the first MTT with NAT non-treatment, 13 patients showed serum TG levels of 200 mg/dL or greater when measured 2 h after the meal. In these 13 patients, NAT administration produced a significant decrease in TG levels 1, 2, and 6 h after the meal, as well as a significant reduction in RLP-TG levels 1 and 2 h after the meal. NAT administration was also associated with significant reductions in area under the curve (DeltaAUC) for TG and RLP-TG. These results suggest that, in a clinical setting, the early insulin response is closely associated with both postprandial glucose and postprandial lipid metabolism in Japanese patients with type 2 diabetes. 相似文献
123.
124.
125.
Nobuaki Sakamoto Huanhuan Hu Akiko Nanri Tetsuya Mizoue Masafumi Eguchi Takeshi Kochi Tohru Nakagawa Toru Honda Shuichiro Yamamoto Takayuki Ogasawara Naoko Sasaki Akiko Nishihara Teppei Imai Toshiaki Miyamoto Makoto Yamamoto Hiroko Okazaki Kentaro Tomita Akihiko Uehara Ai Hori Makiko Shimizu Taizo Murakami Keisuke Kuwahara Ami Fukunaga Isamu Kabe Tomofumi Sone Seitaro Dohi 《Journal of diabetes investigation.》2020,11(3):719-725
126.
127.
128.
Tomoaki Nakamura Yushi Hirota Naoko Hashimoto Tomokazu Matsuda Michinori Takabe Kazuhiko Sakaguchi Wataru Ogawa Susumu Seino 《Journal of diabetes investigation.》2014,5(1):48-50
To estimate the carbohydrate‐to‐insulin ratio (CIR), a formula dividing a constant, usually 300–500, by the total daily dose (TDD) of insulin, is widely utilized. An appropriate CIR varies for each meal of the day, however. Here, we investigate diurnal variation of CIR in hospitalized Japanese type 1 diabetic patients treated with continuous subcutaneous insulin infusion. After optimization of the insulin dose, TDD and total basal insulin dose (TBD) were 34.9 ± 10.2 and 9.3 ± 2.8 units, respectively, with a percentage of TBD to TDD of 27.3 ± 6.0%. The products of CIR and TDD at breakfast, lunch and dinner were 311 ± 63, 530 ± 161, and 396 ± 63, respectively, suggesting that in the formula estimating CIR using TDD, the constant should vary for each meal of the day, and that 300, 500, and 400 are appropriate for breakfast, lunch, and dinner, respectively. 相似文献
129.
130.